ABSTRACT Objective: To determine if an amniotic fluid (AF)-specific marker is present and if its concentration changes with the presence of labor. Study Design: Twenty-six healthy women who gave birth to healthy newborns at term during the period from July 2009 to January 2010 were included in the study. Six candidate markers were assessed by commercially available ELISA kits: interleukin (IL)-6, squamous cell carcinoma (SCC) antigen, insulin-like growth factor (IGFBP)-1, osteopontin (OPN), CA125, and sialyl Tn (STN). Results: The AF/maternal serum (MS) measurement based on IL-6 or SCC has proved to be superior to IGFBP-1, CA125, OPN and STN. Women with spontaneous labor at term had significantly higher IL-6 and IGFBP-1 concentrations in AF compared with those without labor. No significant differences were observed in the AF concentrations of SCC, OPN, CA125 and STN between women with labor and those not in labor. Conclusion: Our observation of IL-6 and SCC in AF may open a new area of research to assess their usefulness as biological markers of obstetrical disorders.
Cite this paper
Naruse, K. , Noguchi, T. , Yoshida, S. , Tsunemi, T. , Shigetomi, H. , Oi, H. and Kobayashi, H. (2012) Identification of interleukin-6 (IL-6) and squamous cell carcinoma (SCC) as amniotic fluid-specific markers. Open Journal of Obstetrics and Gynecology, 2, 147-150. doi: 10.4236/ojog.2012.22028.
 Rutanen, E.M., Pekonen, F. and Karkkainen, T. (1993) Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: Comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membranes. Clinica Chimica Acta, 214, 73-81. doi:10.1016/0009-8981(93)90304-M
 Medina, T.M. and Hill, D.A. (2006) Preterm premature rupture of membranes: Diagnosis and management. American Family Physician, 73, 659-664.
 Albayrak, M., Ozdemir, I., Koc, O., Ankarali, H. and Ozen, O. (2011) Comparison of the diagnostic efficacy of the two rapid bedside immunoassays and combined clinical conventional diagnosis in prelabour rupture of membranes. European Journal of Obstetrics & Gynecology Reproductive Biology, 158, 179-182.
 van der Ham, D.P., van Melick, M.J., Smits, L., Nijhuis, J.G., Weiner, C.P., van Beek, J.H., Mol, B.W. and Willekes, C. (2011) Methods for the diagnosis of rupture of the fetal membranes in equivocal cases: A systematic review. European Journal of Obstetrics & Gynecology Reproductive Biology, 157, 123-127.
 Conde-Agudelo, A. and Romero, R. (2009) Amniotic fluid embolism: An evidence-based review. American Journal of Obstetrics & Gynecology, 201, 445.e1-e13.
 Kanayama, N., Yamazaki, T., Naruse, H., Sumimoto, K., Horiuchi, K. and Terao, T. (1992) Determining zinc coproporphyrin in maternal plasma—A new method for diagnosing amniotic fluid embolism. Clinical Chemistry, 38, 526-529.
 Kobayashi, H., Ohi, H. and Terao, T. (1993) A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc. American Journal of Obstetrics & Gynecology, 168, 848-853.
 Kobayashi, H., Ooi, H., Hayakawa, H., Arai, T., Matsuda, Y., Gotoh, K. and Tarao, T. (1997) Histological diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc epitope. Human Pathology, 28, 428-433.
 Oi, H., Kobayashi, H., Hirashima, Y., Yamazaki, T., Kobayashi, T. and Terao, T. (1998) Serological and immunohistochemical diagnosis of amniotic fluid embolism. Seminars in Thrombosis and Hemostasis, 24, 479-484.
 Oi, H., Naruse, K., Noguchi, T., Sado, T., Kimura, S., Kanayama, N., Terao, T. and Kobayashi, H. (2010) Fatal factors of clinical manifestations and laboratory testing in patients with amniotic fluid embolism. Gynecologic and Obstetric Investigation, 70, 138-144.
 Suminami, Y., Nawata, S. and Kato, H. (1998) Biological role of SCC antigen. Tumour Biology, 19, 488-493.
 Takeshima, N., Suminami, Y., Takeda, O., Abe, H. and Kato, H. (1993) Origin of CA125 and SCC antigen in human amniotic fluid. Asia Oceania Journal of Obstetrics and Gynaecology, 19, 199-204.
 Khosravi, J., Krishna, R.G., Bodani, U., Diamandi, A., Khaja, N., Kalra, B. and Kumar, A. (2007) Immunoassay of serine-phosphorylated isoform of insulin-like growth factor (IGF) binding protein (IGFBP)-1. Clinical Biochemistry, 40, 86-93.
 Menon, R., Camargo, M.C., Thorsen, P., Lombardi, S.J. and Fortunato, S.J. (2008) Amniotic fluid interleukin-6 increase is an indicator of spontaneous preterm birth in white but not black Americans. American Journal of Obstetrics and Gynecology, 198, 77.e1-e7.
 Qu, X., Yang, M., Zhang, W., Liang, L., Yang, Y., Zhang, Y., Deng, B., Gao, W., Liu, J., Yang, Q., Kong, B. and Gong, F. (2008) Osteopontin expression in human decidua is associated with decidual natural killer cells recruitment and regulated by progesterone. In Vivo, 22, 55-61.
 Kobayashi, H., Naruse, K., Sado, T., Noguchi, T., Yoshida, S., Shigetomi, H., Onogi, A. and Oi, H. (2011) Search for amniotic fluid-specific markers: Novel biomarker candidates for amniotic fluid embolism. The Open Women’s Health Journal, 5, 7-15.
 Robertson, S.A., Christiaens, I., Dorian, C.L., Zaragoza, D.B., Care, A.S., Banks, A.M. and Olson, D.M. (2010) Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology, 151, 3996-4006.
 Zenclussen, A.C., Blois, S., Stumpo, R., Olmos, S., Arias, K., Malan Borel, I., Roux, M.E. and Margni, R.A. (2003) Murine abortion is associated with enhanced interleukin6 levels at the feto-maternal interface. Cytokine, 24, 150-160. doi:10.1016/j.cyto.2003.08.002
 Krupa, F.G., Faltin, D., Cecatti, J.G., Surita, F.G. and Souza, J.P. (2006) Predictors of preterm birth. International Journal of Gynaecology & Obstetrics, 94, 5-11.